NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P30
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -19.65% |
| Q3 2025 | -54.74% |
| Q2 2025 | 48.30% |
| Q1 2025 | -59.44% |
| Q4 2024 | -72.90% |
| Q3 2024 | 52.44% |
| Q2 2024 | 5.24% |
| Q1 2024 | -8.63% |
| Q4 2023 | -3.06% |
| Q3 2023 | -16.66% |
| Q2 2023 | -6.60% |
| Q1 2023 | -41.99% |
| Q4 2022 | 0.00% |
| Q3 2022 | -199.93% |
| Q2 2022 | -5.30% |
| Q1 2022 | 264.67% |
| Q4 2021 | -4.25% |
| Q3 2021 | -192.72% |
| Q2 2021 | -1.16% |
| Q1 2021 | -4470.57% |
| Q4 2020 | 90.59% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |